Genomics and the ancient origins of the daptomycin biosynthetic gene cluster

被引:33
作者
Baltz, Richard H. [1 ]
机构
[1] CognoGen Biotechnol Consulting, Indianapolis, IN 46220 USA
关键词
biosynthesis; evolution; genomics; daptomycin; Saccharomonospora midis; Streptomyces roseosporus; NONRIBOSOMAL PEPTIDE SYNTHETASES; STREPTOMYCES-ROSEOSPORUS; ADENYLATION DOMAINS; ANTIBIOTICS; POLYKETIDE; THERAPY; A21978C; A54145;
D O I
10.1038/ja.2010.82
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Daptomycin is a clinically useful lipopeptide antibiotic produced by Streptomyces roseosporus. The antibiotic is assembled by a nonribosomal peptide synthetase (NRPS) mechanism, and the cyclized tridecapeptide contains three non-proteinogenic L-amino acids: ornithine (Orn), 3-methyl-glutamic acid (3mGlu) and kynurinine (Kyn). Daptomycin also has three D-amino acids. The two genes that encode proteins involved in the formation of 3mGlu and Kyn have no known orthologs, and hence they are good probes to search for daptomycin-like gene clusters among newly sequenced actinomycete genomes. A recent search with these genes revealed a daptomycin-like gene cluster in Saccharomonospora viridis, a causative agent for farmer's lung disease. S. viridis has a genome of 4.3 Mb, which is about one half the size of Streptomyces genomes. Searches for other NRPS and polyketide synthase (PKS) genes revealed only one other NRPS gene and no PKS genes in S. virichs. The orthologous lipopeptide biosynthetic genes and gene products in S. viridis and S. roseosporus have diverged extensively from a last common ancestor dating back to a pathway that had evolved over 1 billion years ago. The Journal of Antibiotics (2010) 63, 506-511. doi 10 1038/ja 2010 82, published online 21 July 2010
引用
收藏
页码:506 / 511
页数:6
相关论文
共 36 条
[1]
ALEXANDER DC, APPL ENV MICRO UNPUB
[2]
BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[3]
IMPROVED MEDIUM FOR RECOVERY AND ENUMERATION OF THE FARMERS LUNG ORGANISM, SACCHAROMONOSPORA-VIRIDIS [J].
AMNER, W ;
EDWARDS, C ;
MCCARTHY, AJ .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1989, 55 (10) :2669-2674
[4]
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections [J].
Arbeit, RD ;
Maki, D ;
Tally, FP ;
Campanaro, E ;
Eisenstein, BI .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1673-1681
[5]
Baltz R.H., 2005, SIM News, V55, P186
[6]
Natural products to drugs: daptomycin and related lipopeptide antibiotics [J].
Baltz, RH ;
Miao, V ;
Wrigley, SK .
NATURAL PRODUCT REPORTS, 2005, 22 (06) :717-741
[7]
Biosynthesis and genetic engineering of lipopeptide antibiotics related to daptomycin [J].
Baltz, Richard H. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (08) :618-638
[8]
Baltz RH, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P391
[9]
Renaissance in antibacterial discovery from actinomycetes [J].
Baltz, Richard H. .
CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (05) :557-563
[10]
Predictive, structure-based model of amino acid recognition by nonribosomal peptide synthetase adenylation domains [J].
Challis, GL ;
Ravel, J ;
Townsend, CA .
CHEMISTRY & BIOLOGY, 2000, 7 (03) :211-224